期刊文献+

A群脑膜炎球菌多糖结合物原液中游离糖含量测定方法的建立及其验证 被引量:7

Development and validation of a determination method for free polysaccharide content in bulk of group A meningococcal polysaccharide conjugate
原文传递
导出
摘要 目的 建立A群脑膜炎球菌多糖结合物原液中游离糖含量测定的方法,并进行验证。方法 采用脱氧胆酸钠(sodium deoxycholate,DOC)法,分别取1 ml 10、50、100、150、200、250、294μg/ml载体蛋白破伤风类毒素(tetanus toxoid,TT),与100μl 1%DOC溶液(pH 7.3)混匀,离心收集上清,检测蛋白含量,确定DOC沉淀载体蛋白范围;用不同离子强度梯度的缓冲液(0.2、0.4、0.6、0.8、1.0 mol/L氯化钠)稀释游离多糖与载体蛋白混合物溶液,收集上清,检测多糖含量,确定游离多糖分离条件;以1%DOC溶液作为稀释剂绘制参考品磷含量测定标准曲线,确定DOC存在对磷含量测定结果的影响,建立DOC沉淀蛋白结合磷含量测定方法测定A群脑膜炎球菌多糖结合物中游离糖含量的方法,并对建立的方法进行精密度、准确性及重复性验证。结果DOC沉淀载体蛋白浓度控制在250μg/ml以下;将0.8 mol/L氯化钠溶液作为A群脑膜炎球菌多糖结合物中游离糖含量测定所需最佳稀释液;以1%DOC溶液作为稀释剂绘制的磷含量标准曲线线性范围在0~4μg/ml时,r2为0.999 9。A群脑膜炎球菌多糖结合物原液及游离糖对照品与载体蛋白混合物沉淀中蛋白回收率在95%~110%之间;游离糖添加试验回收率均在95%以上;4批A群脑膜炎球菌多糖蛋白结合物游离糖含量平均值均在规定范围内。结论 建立的DOC沉淀蛋白结合磷含量测定方法可有效分离结合物与游离多糖,并准确测定结合物含量。 Objective To develop and validate a method for determination of free polysaccharide in bulk of group A meningococcal polysaccharide(GAMP)conjugate. Methods A portion of 1 ml of tetanus toxoid(TT)as carrier protein,at concentrations of 1,10,50,100,150,200,250 and 294 μg / ml respectively,were mixed with 100 μl 1% sodium deoxycholate(DOC)(pH 7. 3),and the supernatants were collected by centrifugation and determined for protein content,based on which the range of carrier protein concentration precipitated with DOC was determined. The mixtures of free polysaccharide and carrier protein were diluted with buffers at various ionic strengths(0. 2,0. 4,0. 6,0. 8 and 1. 0 mol / L)sodium chloride,of which the supernatants were collected and tested for polysaccharide content to determine the condition for separation of free polysaccharide. The standard curve for determination of phosphor content was plotted using 1%DOC as a diluent to evaluate the presence of DOC on determination result of phosphorus content. DOC precipitation combined with phosphor content determination method for free polysaccharide content in GAMP conjugate was developed,and verified for precision,accuarcy and reproducibility. Results The carrier protein concentration for DOC precipitation was controlled at less than 250 μg / ml. Sodium chloride at a concentration of 0. 8 mol / L was served as the diluent for determination of free polysaccharide in GAMP conjugate. The linear range of standard curve for determination of phosphorcontent plotted using 1% DOC as a diluent was 0 ~ 4 μg / ml,with a r2 value of 0. 999 9. The recovery rates of proteins in bulk precipitate of GAMP and mixture precipitate of free polysaccharide and carrier protein were 95% ~ 110%. All the recovery rates of free polysaccharide in spiking study were more than 95%. The mean free polysaccharide contents in four batches of GAMP were within the range specified. Conclusion The developed DOC precipitation combined with phosphor determination method was effective for separation of conjugate from free polysaccharide and accurate determination of conjugate content.
出处 《中国生物制品学杂志》 CAS CSCD 2014年第10期1295-1298,1303,共5页 Chinese Journal of Biologicals
基金 国家科技支撑计划课题(2008BAI66B01)
关键词 A群脑膜炎球菌多糖结合物 游离糖 含量测定 Group A meningococcal polysaccharide(GAMP) Free polysaccharide Content determination
  • 相关文献

参考文献7

  • 1Centers for Disease Control and Prevention. Serogroup A meningococcal conjugate vaccine coverage after the first na- tional mass immunization campaign-Burkina Faso, 2011 [J]. MMWR Morb Mortal Wkly Rep, 2012, 61(50): 1022-1024.
  • 2张莉,杨展澜,熊尧,彭疼疼,翁诗甫,吴瑾光.H^+对水溶液中脱氧胆酸钠聚集体的影响[J].物理化学学报,2004,20(10):1196-1199. 被引量:11
  • 3Lei QP, Lamb DH, I-Ieller R, et al. Quantitation of low level unconjugated polysaccharide in tetajnus toxoid-conjugate vaccine by HPAEC/PAD following rapid separation by deoxycholate/HC1 [J]. J Pharm Biomed Anal, 2000, 21(6): 1087-1091.
  • 4卫生部药品审评中心.生物制品质量控制分析方法验证技术评审一般原则[S].2005-12-XX.
  • 5Kim HS, Kim SJ, Kim HJ, et al. Optimization of the Lowry method of protein precipitation from the H. influenzae type b conjugate vaccine using deoxycholic acid and hydrochloric acid [J]. Biotechnol Bioproc Engi, 2006, 11(3): 215-222.
  • 6Lei QP, Shannon AG, Heller RK, et al. Quantification of free polysaccharide in meningococcal polysaceharide-diphtheria tox- oid conjugate vaccines [J]. Dev Biol(Basel), 2000, 103(1): 259-264.
  • 7Guo YY, Anderson R, Mclver J, et al. A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophiluz influenzae type b in PRP-tetanus toxoid conjugate vaccine [J ]. Biologicals, 1998, 26( 1 ) : 33-38.

二级参考文献10

  • 1Li, N.; Gu, Z. Y. Foreign Medical Sciences, 1984, 5:263[李宁, 顾倬云. 国外医学( Guowai Yixue), 1984, 5: 263]
  • 2Small, D. M.; Bougles, M.; Dernichiam, D. G. Nature, 1966,211:816
  • 3Kurtin, W.; Wright, L. K.; Chosed, R. J. Abstracts of Papers of the American Chemical Society, 2000, 21 (9): 611
  • 4Bechi, P.; Cianchi, F.; Mazzanti, R.; Fantappie, O.; Fiorillo, C.;Nassi, P. Diseases of the Esophagus, 2000,13(1): 51
  • 5de Sanctis, S. C.; D'Archivio, A. A.; Galantini, L. Journal of the Chemical Society-Perkin Transactions 2, 2000, (2):403
  • 6Dawes, L. G.; Greiner, M. A.; Joehl, R. J. Journal of Surgical Research, 1999, 81 (1): 21
  • 7Zhang, L.; Yang, Z. L.; Soloway, R. D.; Weng, S. F.; Wu, J. G.Gastroenterology, 2000, 118(4): 310
  • 8Zhang, L.; Yang, Z. L.; Soloway, R. D.; Weng, S. F.; Wu, J. G.Gastroenterology, 2001, 120 (5): 1067
  • 9Bian, J.; Weng, S. F.; Wu, J. G.; Yang, L. Q.; Zhang, X.; Xu,G. X. Mikrochim. Acta, 1997,1(14): 367
  • 10Small, D. M. Bile acids. New York: Plennum Press, 1971:249

共引文献10

同被引文献48

  • 1张莉,杨展澜,熊尧,彭疼疼,翁诗甫,吴瑾光.H^+对水溶液中脱氧胆酸钠聚集体的影响[J].物理化学学报,2004,20(10):1196-1199. 被引量:11
  • 2Jódar L,Griffiths E,Feavers I.Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines[J].Vaccine,2004,22(8):1047-1053.
  • 3Suker J,Feavers IM,Corbel MJ,et al.Control and lot release of meningococcal group C conjugate vaccines[J].Expert Rev Vaccines,2004,3(5):533-540.
  • 4Pace D,Pollard AJ,Messonier NE.Quadrivalent meningococcal conjugate vaccines[J].Vaccine,2009,27(Suppl 2):B30-B41.
  • 5Bardotti A,Averani G,Berti F,et al.Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases[J].Vaccine,2008,26(18):2284-2296.
  • 6Papaevangelou V,Spyridis N.Men ACWY-TT vaccine for active immunization against invasive meningococcal disease[J].Expert Rev Vaccines,2012,11(5):523-537.
  • 7Jumel K,Ho MM,Bolgiano B.Evaluation of meningococcal C oligosaccaride conjugate vaccines by size-exclusion chromatography/multi-angle laser light scattering[J].Biotechnol Appl Biochem,2002,36(Pt 3):219-226.
  • 8Jones C.NMR assays for carbohydrate-based vaccines[J].J Pharm Biomed Anal,2005,38(5):840-850.
  • 9Lemercinier X,Jones C.Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production[J].Carbohydr Res,1996,296(1):83-96.
  • 10Trauger SA,Webb W,Siuzdak G.Peptide and protein analysis with mass spectrometry[J].Spectroscopy,2002,16(1):15-28.

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部